139 related articles for article (PubMed ID: 35241556)
1. Role of Adjuvant Treatment in High-risk Patients Following Resection for Gallbladder Cancer.
Park Y; Kim K; Park HJ; Chun HJ; Choi D; Kim K
In Vivo; 2022; 36(2):961-968. PubMed ID: 35241556
[TBL] [Abstract][Full Text] [Related]
2. Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma.
Kim WS; Choi DW; You DD; Ho CY; Heo JS; Choi SH
J Gastrointest Surg; 2010 Apr; 14(4):679-87. PubMed ID: 20094817
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma.
Kresl JJ; Schild SE; Henning GT; Gunderson LL; Donohue J; Pitot H; Haddock MG; Nagorney D
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):167-75. PubMed ID: 11777635
[TBL] [Abstract][Full Text] [Related]
4. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
[TBL] [Abstract][Full Text] [Related]
5. Postoperative radiotherapy for gallbladder cancer.
Jeong Y; Park JH; Lee YJ; Park KM; Hwang S; Chang HM; Kim KP; Yoon SM; Jung NH; Kim JH
Anticancer Res; 2014 Oct; 34(10):5621-9. PubMed ID: 25275065
[TBL] [Abstract][Full Text] [Related]
6. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.
Jarnagin WR; Ruo L; Little SA; Klimstra D; D'Angelica M; DeMatteo RP; Wagman R; Blumgart LH; Fong Y
Cancer; 2003 Oct; 98(8):1689-700. PubMed ID: 14534886
[TBL] [Abstract][Full Text] [Related]
7. Influence of adjuvant therapy on pattern of failure and survival in curatively resected gallbladder carcinoma.
Choudhary S; Gupta N; Verma CP; Das A; Aggarwal LM; Tewari M; Mandal A; Asthana AK
J Cancer Res Ther; 2021; 17(4):1064-1068. PubMed ID: 34528565
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience.
Wang J; Narang AK; Sugar EA; Luber B; Rosati LM; Hsu CC; Fuller CD; Pawlik TM; Miller RC; Czito BG; Tuli R; Crane CH; Ben-Josef E; Thomas CR; Herman JM
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S1100-6. PubMed ID: 26224402
[TBL] [Abstract][Full Text] [Related]
9. Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04).
Lee SU; Seong J; Kim TH; Im JH; Kim WC; Kim K; Park HJ; Kim TG; Kim Y; Jeong BK; Kim JH; Kim BH; Nam TK
Cancer Biol Med; 2021 Dec; 19(6):931-44. PubMed ID: 34919359
[TBL] [Abstract][Full Text] [Related]
10. Postoperative recurrent patterns of gallbladder cancer: possible implications for adjuvant therapy.
Yuan Z; Shui Y; Liu L; Guo Y; Wei Q
Radiat Oncol; 2022 Jul; 17(1):118. PubMed ID: 35799270
[TBL] [Abstract][Full Text] [Related]
11. Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium.
Margonis GA; Gani F; Buettner S; Amini N; Sasaki K; Andreatos N; Ethun CG; Poultsides G; Tran T; Idrees K; Isom CA; Fields RC; Krasnick B; Weber SM; Salem A; Martin RC; Scoggins C; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Maithel SK; Pawlik TM
HPB (Oxford); 2016 Nov; 18(11):872-878. PubMed ID: 27527802
[TBL] [Abstract][Full Text] [Related]
12. Estimating survival benefit of adjuvant therapy based on a Bayesian network prediction model in curatively resected advanced gallbladder adenocarcinoma.
Geng ZM; Cai ZQ; Zhang Z; Tang ZH; Xue F; Chen C; Zhang D; Li Q; Zhang R; Li WZ; Wang L; Si SB
World J Gastroenterol; 2019 Oct; 25(37):5655-5666. PubMed ID: 31602165
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant radiotherapy improves long-term survival after resection for gallbladder cancer A population-based cohort study.
Kamarajah SK; Al-Rawashdeh W; White SA; Abu Hilal M; Salti GI; Dahdaleh FS
Eur J Surg Oncol; 2022 Feb; 48(2):425-434. PubMed ID: 34518052
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in patients with gallbladder cancer after surgical resection: analysis of 279 operated patients.
Lim H; Seo DW; Park DH; Lee SS; Lee SK; Kim MH; Hwang S
J Clin Gastroenterol; 2013; 47(5):443-8. PubMed ID: 23188077
[TBL] [Abstract][Full Text] [Related]
15. Multimodality management of gallbladder cancer can lead to a better outcome: Experience from a tertiary care oncology centre in North India.
Goel S; Aggarwal A; Iqbal A; Talwar V; Mitra S; Singh S
World J Gastroenterol; 2021 Dec; 27(45):7813-7830. PubMed ID: 34963744
[TBL] [Abstract][Full Text] [Related]
16. Postoperative adjuvant chemotherapy and radiotherapy for stage II and III non-small cell lung cancer (NSCLC).
Lee SW; Choi EK; Chung WK; Shin KH; Ahn SD; Kim JH; Kim SW; Suh C; Lee JS; Kim WS; Kim DS; Kim DK; Park SI; Sohn KH
Lung Cancer; 2002 Jul; 37(1):65-71. PubMed ID: 12057869
[TBL] [Abstract][Full Text] [Related]
17. Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.
Chua DT; Wei WI; Sham JS; Cheng AC; Au G
Head Neck; 2003 Jul; 25(7):585-94. PubMed ID: 12808662
[TBL] [Abstract][Full Text] [Related]
18. Locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy.
Song S; Kim K; Chie EK; Kim S; Park HJ; Yi NJ; Suh KS; Ha SW
Clin Transl Oncol; 2015 Oct; 17(10):825-9. PubMed ID: 26041722
[TBL] [Abstract][Full Text] [Related]
19. A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder Cancer.
Ozer M; Goksu SY; Sanford NN; Porembka M; Khurshid H; Ahn C; Maxwell MC; Beg MS; Kazmi SM
JAMA Netw Open; 2022 Feb; 5(2):e2146912. PubMed ID: 35171262
[TBL] [Abstract][Full Text] [Related]
20. Validation of the oncologic effect of hepatic resection for T2 gallbladder cancer: a retrospective study.
Cho JK; Lee W; Jang JY; Kim HG; Kim JM; Kwag SJ; Park JH; Kim JY; Park T; Jeong SH; Ju YT; Jung EJ; Lee YJ; Hong SC; Jeong CY
World J Surg Oncol; 2019 Jan; 17(1):8. PubMed ID: 30616645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
